ozone application shows circulatory and retinal tissue support in age-related conditions
Ozone therapy in chronic limb ischemia produces therapeutic results superior to prostanoid infusions and at lower cost, benefiting approximately 70% of patients with age-related macular degeneration (dry form).
What this means for you
Poor circulation and age-related changes in the eyes are two things conventional options often struggle to address. Research suggests ozone application may support blood flow in compromised limbs and benefit roughly 70% of people with dry macular degeneration — a condition with very few alternatives. For wellness-focused individuals, that points to meaningful support for both vascular and visual resilience as we age.
The published research
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.